Anesthetic management of patients with pulmonary hypertension

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 12, Issue 2, 2008, Pages 91-96

  MacKnight, Brenda ^a   Martinez, Elizabeth A ^a   Simon, Brett A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tower 711 ^*  (United States)

Author keywords

Anesthetic management; Pharmacotherapy; Pulmonary hypertension; Right ventricular function

Indexed keywords

ADENOSINE; AMBRISENTAN; AMINOTRANSFERASE; AMLODIPINE; ANTICOAGULANT AGENT; BENZODIAZEPINE; BERAPROST; BOSENTAN; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIURETIC AGENT; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; ILOPROST; MILRINONE; MUSCLE RELAXANT AGENT; NIFEDIPINE; NITRIC OXIDE; OPIATE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; SILDENAFIL; SITAXSENTAN; STEROID; UNIPROST; VASODILATOR AGENT;

AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA; ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; BIRTH DEFECT; CARDIOVASCULAR FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTINUOUS INFUSION; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; ELECTIVE SURGERY; FUNCTIONAL STATUS; GENERAL ANESTHESIA; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE CONTRACTILITY; HUMAN; LIVER DYSFUNCTION; LONGEVITY; LUNG FIBROSIS; MORBIDITY; OUTPATIENT; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT SAFETY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; PULMONARY HYPERTENSION; RECOMMENDED DRUG DOSE; RESPIRATORY FAILURE; REVIEW; SIDE EFFECT; SURGICAL MORTALITY; SURGICAL PATIENT; THROMBOEMBOLISM; THROMBOSIS; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ANESTHESIA; HUMANS; HYPERTENSION, PULMONARY; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; RESPIRATION, ARTIFICIAL; SURGICAL PROCEDURES, ELECTIVE;

EID: 47549083107     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/1089253208319872     Document Type: Review

References (12)

1. Ramakrishna G., Sprung J., Ravi BS, Chandrasekaran K., McGoon MD Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005 ; 45: 1691-1699.
2. Hoeper MM, Rubin LJ Update in pulmonary hypertension 2005. Am J Respir Crit Care Med. 2006 ; 173: 499-505.
3. Humbert M., Sitbon O., Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004 ; 351: 1425-1436.
4. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004 ; 351: 1655-1665.
5. Blaise G., Langleben D., Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology. 2003 ; 99: 1415-1432.
6. Badesch DB, Abman SH, Simonneau G., Rubin LJ, McLaughlin VV Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest. 2007 ; 131: 1917-1928.
7. Simonneau G., Galiè N., Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004 ; 43: 5S - 12S.
8. Gaine S. Pulmonary hypertension. JAMA. 2000 ; 284: 3160-3168.
9. Galie N., Ghofrani HA, Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005 ; 353: 2148-2157.
10. Barst RJ, Galie N., Naeije R., et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J. 2006 ; 28: 1195-1203.
11. McLaughlin VV, Oudiz RJ, Frost A., et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006 ; 174: 1257-1263.
12. Kleen M., Zwissler B. Intra-operative use of inhaled vasodilators: are there indications ? Curr Opin Anaesthesiol. 2002 ; 15: 79-83.